Abstract
THE brain cholecystokinin-B/gastrin receptor (CCK-B/gastrin) has been implicated in mediating anxiety, panic attacks, satiety, and the perception of pain1–5. The canine and human CCK-B/gastrin receptors share 90% amino-acid identity6,7 and have similar agonist affinities. These receptors can be selectively blocked by the non-peptide benzodiazepine-based antagonists L365260 (ref. 8) and L364718 (ref . 9) ; however, the binding of these antagon-ists to the human and canine receptors differs by up to 20-fold, resulting in a reversal of affinity rank order. Here we report the identification of a single amino acid in the sixth transmembrane domain of the CCK-B/gastrin receptor that corresponds to valine 319 in the human homologue and which is critical in determining the binding affinity for these non-peptide antagonists. We show that it is the variability in the aliphatic side chain of the amino acid in position 319 that confers antagonist specificity. Substitution of valine 319 with a leucine residue decreases the affinity for L365260 20-fold while concomitantly increasing the affinity for L364718. An isoleucine in the same position of the human receptor selectively increases affinity for L364718. Interspecies differences in the aliphatic amino acid occupying this single position selectively affect antagonist affinities without altering the agonist binding profile6,7,10. We therefore conclude that the residues underlying non-peptide antagonist affinity must differ from those that confer agonist specificity. To our knowledge, these findings are the first example in which a critical antagonist binding determinant for a seven-transmembrane-domain peptide hormone receptor has been identified.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ravard, S. & Dourish, C. T. Trends Pharmac. Sci. 11, 271–273 (1990).
Faris, P. L., Komisaruk, B. R., Watkins, L. R. & Mayer, D. J. Science 219, 310–312 (1983).
Dourish, C. T. et al. Eur. J. Pharmac. 176, 35–44 (1990).
Wiertelak, E. P., Maier, S. F. & Watkins, L. R. Science 256, 830–833 (1992).
Dourish, C. T., Rycroft, W. & Iversen, S. D. Science 245, 1509–1511 (1989).
Kopin, A. S. et al. Proc. natn. Acad. Sci. U.S.A. 89, 3605–3609 (1992).
Lee, Y. M. et al. J. biol. Chem. (in the press).
Lotti, V. J. & Chang, R. S. Eur. J. Pharmac. 162, 273–280 (1989).
Chang, R. S. & Lotti, V. J. Proc. natn. Acad. Sci. U.S.A. 83, 4923–4926 (1986).
Nakata, H. et al. Biochem. biophys. Res. Commun. 187, 1151–1157 (1992).
Wank, S. A., Pisegna, J. R. & de Weerth, A. Proc. natn. Acad. Sci. U.S.A. 89, 8691–8695 (1992).
Wank, S. A. et al. Proc. natn. Acad. Sci. U.S.A. 89, 3125–3129 (1992).
Oksenberg, D. et al. Nature 360, 161–163 (1992).
Kunkel, T. A. Proc. natn. Acad. Sci. U.S.A. 82, 488–492 (1985).
Eghtedarzadeh, M. K. & Henikoff, S. Nucleic Acids Res. 14, 5115 (1986).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Beinborn, M., Lee, YM., McBride, E. et al. A single amino acid of the cholecystokinin-B/gastrin receptor determines specificity for non-peptide antagonists. Nature 362, 348–350 (1993). https://doi.org/10.1038/362348a0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/362348a0
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.